These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2144873

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
    Redding TW, Schally AV, Radulovic S, Milovanovic S, Szepeshazi K, Isaacs JT.
    Cancer Res; 1992 May 01; 52(9):2538-44. PubMed ID: 1568223
    [Abstract] [Full Text] [Related]

  • 3. Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75).
    Bokser L, Srkalovic G, Szepeshazi K, Schally AV.
    Neuroendocrinology; 1991 Aug 01; 54(2):136-45. PubMed ID: 1662786
    [Abstract] [Full Text] [Related]

  • 4. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J, Lamharzi N, Halmos G, Groot K, Jungwirth A, Vadillo-Buenfil M, Kakar SS, Schally AV.
    Endocrinology; 1996 Aug 01; 137(8):3430-6. PubMed ID: 8754771
    [Abstract] [Full Text] [Related]

  • 5. Suppression of meiosis of male germ cells by an antagonist of luteinizing hormone-releasing hormone.
    Szende B, Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1990 Feb 01; 87(3):901-3. PubMed ID: 2405399
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
    Yano T, Pinski J, Szepeshazi K, Milovanovic SR, Groot K, Schally AV.
    Prostate; 1992 Feb 01; 20(4):297-310. PubMed ID: 1351672
    [Abstract] [Full Text] [Related]

  • 8. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
    Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV.
    Endocrinology; 1990 Dec 01; 127(6):3052-60. PubMed ID: 2174343
    [Abstract] [Full Text] [Related]

  • 9. New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues.
    Bajusz S, Csernus VJ, Janaky T, Bokser L, Fekete M, Schally AV.
    Int J Pept Protein Res; 1988 Dec 01; 32(6):425-35. PubMed ID: 2469662
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat.
    Ayalon D, Farhi Y, Comaru-Schally AM, Schally AV, Eckstein N, Vagman I, Limor R.
    Neuroendocrinology; 1993 Aug 01; 58(2):153-9. PubMed ID: 8264861
    [Abstract] [Full Text] [Related]

  • 12. Blockade of the LH response induced by the agonist D-Trp-6-LHRH in rats by a highly potent LH-RH antagonist SB-75.
    Pinski J, Yano T, Miller G, Schally AV.
    Prostate; 1992 Aug 01; 20(3):213-24. PubMed ID: 1533453
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of pituitary-testicular function with [D-Trp6] luteinizing hormone-releasing hormone in rhesus monkeys.
    Sundaram K, Connell KG, Bardin CW, Samojlik E, Schally AV.
    Endocrinology; 1982 Apr 01; 110(4):1308-14. PubMed ID: 6460610
    [Abstract] [Full Text] [Related]

  • 15. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Szende B, Srkalovic G, Groot K, Lapis K, Schally AV.
    Cancer Res; 1990 Jun 15; 50(12):3716-21. PubMed ID: 2160323
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone.
    Reissmann T, Hilgard P, Harleman JH, Engel J, Comaru-Schally AM, Schally AV.
    J Cancer Res Clin Oncol; 1992 Jun 15; 118(1):44-9. PubMed ID: 1530849
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75.
    Korkut E, Bokser L, Comaru-Schally AM, Groot K, Schally AV.
    Proc Natl Acad Sci U S A; 1991 Feb 01; 88(3):844-8. PubMed ID: 1992476
    [Abstract] [Full Text] [Related]

  • 19. Administration of an LHRH-antagonist to male mice: effects on in vivo secretion of hormones and on the growth of a transplantable human prostatic carcinoma.
    van Steenbrugge GJ, Ultee-van Gessel AM, Groen M, de Jong FH, Schroeder FH.
    Life Sci; 1987 Mar 30; 40(13):1335-43. PubMed ID: 3104711
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.